Pharmafile Logo
Pharmafocus logo
Advanced Search

Gilead

Showing 15 posts of 244 posts found.

philippe_bishop_gilead

Gilead secures senior head from Genentech

December 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Gilead, Philippe Bishop

Dr Philippe Bishop is joining the California-based biopharma firm Gilead from Genentech to be the company’s senior vice president of …

Appointment
Sovaldi image

Gilead sued over Sovaldi price

December 15, 2014
Sales and Marketing BMS, Gilead, NICE, harvoni, hep C, septa, sofosbuvir, sovaldi

A payer is suing Gilead over the price of its hep-c drug Sovaldi in the US after spending $2.4 million …

News
Kadcyla image

Global drug spending set to top $1 trillion

November 20, 2014
Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend

Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …

News
Harvoni image

Gilead gets Harvoni boost for Europe

November 20, 2014
Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi

Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …

News
BMS image

BMS claims advance with hepatitis C regimen

November 10, 2014
Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi

Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …

News
Sovaldi image

Sovaldi misses estimates but still makes history

October 29, 2014
Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …

News
gilead_hq_at_stockley_park_london

Gilead to shift plant and expand US manufacturing

September 30, 2014
Manufacturing and Production AmBisome, Cayston, Gilead, San Dimas, Viread, california, manufacturing

Gilead Sciences will move its US manufacturing plant about 15 minutes down the road to a 23-acre site in the …

News

Sovaldi combo sees CHMP green light

September 29, 2014
Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi

The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …

News
Zydelig image

Gilead’s blood cancer pill approved in Europe

September 22, 2014
Sales and Marketing CLL, Gilead, blood cancer, fl, idelalisib, oncology, zydelig

Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further …

News
Sovaldi image

Gilead allows generic prices for Sovaldi

September 16, 2014
Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi

Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …

News
Incivek image

Vertex ditches its once-stellar hep C drug

August 14, 2014
Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi

Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …

News
Roche

Roche’s blood cancer drug gains EU approval

July 29, 2014
Research and Development, Sales and Marketing CLL, Cancer, Gilead, Janssen, Roche

The European Commission has approved Roche’s new leukaemia drug Gazyvaro (obinutuzumab) as competition for the blood cancer market heats up. …

News
EMA HQ

EMA approvals for rival blood cancer drugs

July 27, 2014
Research and Development, Sales and Marketing CLL, Gilead, Janssen, chronic lymphocytic leukaemia, imbruvica, zydelig

Gilead and Janssen are set to face off in Europe after the CHMP recommended both of their rival blood cancer …

News
Gilead image

FDA approves Gilead’s blood cancer drug

July 24, 2014
Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …

News
Sovaldi (sofosbuvir) image

Sovaldi scores in HIV patients

July 21, 2014
Sales and Marketing Gilead, HIV, JAMA, hep C, hepatitis C, sovaldi

Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025